Differences in Autoantibody Profiles and Disease Activity and Damage Scores Between Childhood- and Adult-Onset Systemic Lupus Erythematosus: A Meta-Analysis

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 3, 2012, Pages 271-280

  Livingston, Brieanna ^a   Bonner, Ashley ^b   Pope, Janet ^a,c  

^a WESTERN UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Adult; Autoantibodies; Differences; Pediatric; SLE (Lupus, Systemic Lupus Erythematosus); SLE damage index (SLICC SDI); SLE disease activity; SLEDAI

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LA ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RIBONUCLEOPROTEIN U1 ANTIBODY; RO ANTIBODY; SINGLE STRANDED DEOXYRIBONUCLEIC ACID ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; COOMBS TEST; DISEASE ACTIVITY; HUMAN; META ANALYSIS (TOPIC); ONSET AGE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DAMAGE INDEX; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX;

AGE FACTORS; AGE OF ONSET; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDLINE; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 84869112139     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.05.001     Document Type: Article

References (41)

1. Merkel P.A. Systemic lupus erythematosus. Cecil essentials of medicine 2004, 745-749. W. B. Saunders, Philadelphia (PA). 6th ed. T.E. Andreoli, C.C.J. Carpenter, R.C. Griggs, J. Loscalzo (Eds.).
2. Klein-Gitelman M., Reiff A., Silverman E.D. Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 2002, 28(3):561-577. vi-vii.
3. Livingston B., Bonner A., Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: A meta-analysis. Lupus 2011, 20:1345-1355.
4. Mina R., Brunner H.I. Pediatric lupus-Are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?. Rheum Dis Clin North Am 2010, 36(1):53-80. vii-viii.
5. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35(6):630-640.
6. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369.
7. Liang M.H., Socher S.A., Larson M.G., Schur P.H. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989, 32(9):1107-1118.
8. Brunner H.I., Feldman B.M., Bombardier C., Silverman E.D. Sensitivity of the systemic lupus erythematosus disease activity index, British Isles Lupus Assessment Group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999, 42(7):1354-1360.
9. Brunner H.I., Silverman E.D., To T., Bombardier C., Feldman B.M. Risk factors for damage in childhood-onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002, 46(2):436-444.
10. Dayal N.A., Gordon C., Tucker L., Isenberg D.A. The SLICC damage index: Past, present and future. Lupus 2002, 11(4):261-265.
11. Bandeira M., Buratti S., Bartoli M., Gasparini C., Breda L., Pistorio A., et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 2006, 15(8):515-520.
12. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25(11):1271-1277.
13. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 2007, 335(7624):806-808.
14. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
15. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
16. Brunner H.I., Gladman D.D., Ibañez D., Urowitz M.D., Silverman E.D. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008, 58(2):556-562.
17. Carreño L., López-Longo F.J., Monteagudo I., Rodríguez-Mahou M., Bascones M., González C.M., et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999, 8(4):287-292.
18. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993, 72(2):113-124.
19. Font J., Cervera R., Espinosa G., Pallarés L., Ramos-Casals M., Jiménez S., et al. Systemic lupus erythematosus (SLE) in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998, 57(8):456-459.
20. Gómez J., Suárez A., López P., Mozo L., Díaz J.B., Gutiérrez C. Systemic lupus erythematosus in Asturias, Spain: Clinical and serologic features. Medicine (Baltimore) 2006, 85(3):157-168.
21. Hashimoto H., Tsuda H., Hirano T., Takasaki Y., Matsumoto T., Hirose S. Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol 1987, 14(3):497-501.
22. Hoffman I.E., Lauwerys B.R., De Keyser F., Huizinga T.W., Isenberg D., Cebecauer L., et al. Juvenile-onset systemic lupus erythematosus: Different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 2009, 68(3):412-415.
23. Janwityanujit S., Totemchokchyakarn K., Verasertniyom O., Vanichapuntu M., Vatanasuk M. Age-related differences on clinical and immunological manifestations of SLE. Asian Pac J Allergy Immunol 1995, 13(2):145-149.
24. Mok C.C., Mak A., Chu W.P., To C.H., Wong S.N. Long-term survival of southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups. Medicine (Baltimore) 2005, 84(4):218-224.
25. Pande I., Sekharan N.G., Kailash S., Uppal S.S., Singh R.R., Kumar A., et al. Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults. Lupus 1993, 2(2):83-87.
26. Ramírez Gómez L.A., Uribe Uribe O., Osio Uribe O., Grisales Romero H., Cardiel M.H., Wojdyla D., et al. Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus 2008, 17(6):596-604.
27. Rood M.J., ten Cate R., van Suijlekom-Smit L.W.A., den Ouden E.J., Ouwerkerk F.E., Breedveld F.C., et al. Childhood-onset systemic lupus erythematosus: Clinical presentation and prognosis in 31 patients. Scan. J Rheumatol 1999, 28(4):222-226.
28. Shergy W.J., Kredich D.W., Pisetsky D.S. Patterns of autoantibody expression in pediatric and adult systemic lupus erythematosus. J Rheumatol 1989, 16(10):1329-1334.
29. Tucker L.B., Menon S., Schaller J.G., Isenberg D.A. Adult- and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995, 34(9):866-872.
30. Tucker L.B., Uribe A.G., Fernández M., Vilá L.M., McGwin G., Apte M., et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008, 17(4):314-322.
31. Ward M.M., Dawson D.V., Kredich D.W., Pisetsky D.S. Expression of IgM and IgG autoantibodies in pediatric and adult systemic lupus erythematosus. Clin Immunol Immunopathol 1990, 55(2):273-284.
32. Costallat L.T., Coimbra A.M. Systemic lupus erythematosus: Clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 1994, 12(6):603-607.
33. Feng J.B., Ni J.D., Yao X., Pan H.F., Li X.P., Xu J.H., et al. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int 2010, 30(8):1017-1023.
34. Lehman T.J., Hanson V., Zvaifler N., Sharp G., Alspaugh M. Antibodies to nonhistone nuclear antigens and antilymphocyte antibodies among children and adults with systemic lupus erythematosus and their relatives. J Rheumatol 1984, 11(5):644-647.
35. Papadimitraki E.D., Isenberg D.A. Childhood- and adult-onset lupus: An update of similarities and differences. Expert Rev Clin Immunol 2009, 5(4):391-403.
36. Coca A., Sanz I. B cell depletion in lupus and Sjögren's syndrome: An update. Curr Opin Rheumatol 2009, 21(5):483-488.
37. Kallenberg C.G., Stegeman C.A., Bootsma H., Bijl M., Limburg P.C. Quantitation of autoantibodies in systemic autoimmune diseases: Clinically useful?. Lupus 2006, 15(7):397-402.
38. Sène D., Piette J.C., Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 2008, 7(4):272-277.
39. Rinder R. Disorders of hemostasis: Thrombosis. Cecil essentials of medicine 2004, 505-513. W. B. Saunders, Philadelphia (PA). 6th ed. C.C.J. Carpenter, R.C. Griggs, J. Loscalzo (Eds.).
40. Korn J.H. Approach to the patient with rheumatic disease. Cecil essentials of medicine 2004, 731-734. W. B. Saunders, Philadelphia (PA). 6th ed. C.C.J. Carpenter, R.C. Griggs, J. Loscalzo (Eds.).
41. Peschken C.A., Katz S.J., Silverman E., Pope J.E., Fortin P.R., Pineau C., et al. The 1000 Canadian faces of lupus: Determinants of disease outcome in a large multiethnic cohort. J Rheumatol 2009, 36(6):1200-1208.